Raxar en es it fr

Raxar Brand names, Raxar Analogs

Raxar Brand Names Mixture

  • No information avaliable

Raxar Chemical_Formula

C19H22FN3O3

Raxar RX_link

http://www.rxlist.com/cgi/generic2/grepa.htm

Raxar fda sheet

Raxar msds (material safety sheet)

Raxar MSDS

Raxar Synthesis Reference

No information avaliable

Raxar Molecular Weight

359.395 g/mol

Raxar Melting Point

No information avaliable

Raxar H2O Solubility

No information avaliable

Raxar State

Solid

Raxar LogP

2.119

Raxar Dosage Forms

Tablet

Raxar Indication

For treatment of adults with mild to moderate infections caused by susceptible strains of Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis.

Raxar Pharmacology

No information avaliable

Raxar Absorption

Rapidly and extensively absorbed following oral administration. The absolute bioavailability is approximately 70%.

Raxar side effects and Toxicity

Withdrawn from the US market in 1999 due to associations with QTc prolongation and adverse cardiovascular events.

Raxar Patient Information

No information avaliable

Raxar Organisms Affected

Enteric bacteria and other eubacteria